Bayer blood clot drug Trasylol associated with increased health risks - study - Forbes.com

Bayer blood clot drug Trasylol associated with increased health risks - study - Forbes.com: "LEVERKUSEN, Germany (AFX) - Bayer AG's blood clot drug Trasylol (Aprotinin) has been associated with increased risk of kidney failure, of higher stroke risk and encephalopathy -- any degenerative disease of the brain -- in cardiac surgery, according to a study published in the New England Journal of Medicine. "